Skip to main content
SpringerLink
Log in

Imaging and depression in multiple sclerosis: a historical perspective

  • Review Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Purpose

Patients affected with multiple sclerosis suffer from depression more frequently than the general population. Beyond psychosocial, genetic and immune-inflammatory factors, also the brain damage which is peculiar of multiple sclerosis has been claimed to have a role in the aetiology of depression in those patients. The study of this interesting relation has been implemented with both conventional and advanced magnetic resonance imaging techniques. The aim of this review is to provide a historical perspective on the link between multiple sclerosis-related depression and structural and functional brain damage.

Methods

In this review, the results of the MRI studies regarding multiple sclerosis-related brain damage and the presence of depression are presented.

Results

The findings of the reports reveal a link between brain pathology and depressive symptoms or the diagnosis of depression in multiple sclerosis.

Conclusions

Although a multifactorial aetiology has been theorized for depression and depressive symptoms in patients with multiple sclerosis, this review supports the hypothesis that the structural and functional brain impairment might substantially be amongst those factors. Thus, depression itself might be a symptom with a neuro-biological basis and not only the consequence of the disability derived from the neurological impairment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Solaro C, Gamberini G, Masuccio FG (2018) Depression in multiple sclerosis: epidemiology, aetiology, diagnosis and treatment. CNS Drugs 32:117–133. https://doi.org/10.1007/s40263-018-0489-5

    Article  PubMed  Google Scholar 

  2. Solaro C, Trabucco E, Signori A, Martinelli V, Radaelli M, Centonze D, Rossi S, Grasso MG, Clemenzi A, Bonavita S, D’Ambrosio A, Patti F, D’Amico E, Cruccu G, Truini A (2016) Depressive symptoms correlate with disability and disease course in multiple sclerosis patients: an Italian multi-center study using the Beck Depression Inventory. PLoS One 11:1–9. https://doi.org/10.1371/journal.pone.0160261

    Article  CAS  Google Scholar 

  3. Alba Palé L, León Caballero J, Samsó Buxareu B, Salgado Serrano P, Pérez Solà V (2017) Systematic review of depression in patients with multiple sclerosis and its relationship to interferonβ treatment. Mult Scler Relat Disord 17:138–143. https://doi.org/10.1016/j.msard.2017.07.008

    Article  PubMed  Google Scholar 

  4. Feinstein A, Magalhaes S, Richard J et al (2014) The link between multiple sclerosis and depression. Nat Publ Gr 10:507–517. https://doi.org/10.1038/nrneurol.2014.139

    Article  Google Scholar 

  5. Wattjes MP, Rovira À, Miller D et al (2015) Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis - establishing disease prognosis and monitoring patients. Nat Rev Neurol 11:597–606. https://doi.org/10.1038/nrneurol.2015.157

    Article  CAS  PubMed  Google Scholar 

  6. Honer WG, Hurwitz T, Li DKB, Palmer M, Paty DW (1987) Temporal lobe involvement in multiple sclerosis patients with psychiatric disorders. Arch Neurol 44:187–190. https://doi.org/10.1001/archneur.1987.00520140053017

    Article  CAS  PubMed  Google Scholar 

  7. Reischies FM, Baum K, Bräu H et al (1988) Cerebral magnetic resonance imaging findings in multiple sclerosis. Arch Neurol 8:8–10

    Google Scholar 

  8. Ron MA, Logsdail SJ (1989) Psychiatric morbidity in multiple sclerosis: a clinical and MRI study. Psychol Med 19:887–895. https://doi.org/10.1017/S0033291700005602

    Article  CAS  PubMed  Google Scholar 

  9. Millefiorini E, Paduvani A, Pozzili C et al (1992) Depression in the early phase of MS: influence of functional disability, cognitive impairment and brain abnormalities. Acta Neurol Scand 86:354–358

    Article  CAS  Google Scholar 

  10. Sabatini U, Pozzilli C, Pantano P, Koudriavtseva T, Padovani A, Millefiorini E, Biasi CD, Gualdi GF, Salvetti M, Lenzi GL (1996) Involvement of the limbic system in multiple sclerosis patients with depressive disorders. Biol Psychiatry 39:970–975. https://doi.org/10.1016/0006-3223(95)00291-X

    Article  CAS  PubMed  Google Scholar 

  11. George MS, Kellner CH, Bernstein H, Goust JM (1994) A magnetic resonance imaging investigation into mood disorders in multiple sclerosis: a pilot study. J Nerv Ment Dis 182:410–412

    Article  CAS  Google Scholar 

  12. Pujol J, Bello J, Deus J, Marti-Vilalta JL, Capdevila A (1997) Lesions in the left arcuate fasciculus region and depressive symptoms in multiple sclerosis. Neurology 49:1105–1110. https://doi.org/10.1212/WNL.49.4.1105

    Article  CAS  PubMed  Google Scholar 

  13. Pujol J, Bello J, Deus J, Cardoner Ń, Martı́-Vilalta JL, Capdevila A (2000) Beck Depression Inventory factors related to demyelinating lesions of the left arcuate fasciculus region. Psychiatry Res - Neuroimaging 99:151–159. https://doi.org/10.1016/S0925-4927(00)00061-5

    Article  CAS  Google Scholar 

  14. Berg D, Supprian T, Thomae J, Warmuth-Metz M, Horowski A, Zeiler B, Magnus T, Rieckmann P, Becker G (2000) Lesion pattern in patients with multiple sclerosis and depression. Mult Scler 6:156–162. https://doi.org/10.1177/135245850000600304

    Article  CAS  PubMed  Google Scholar 

  15. Bakshi R, Czarnecki CAD, Shaikh ZA et al (2000) Brain MRI lesions and atrophy are related to depression in multiple sclerosis. Neuroreport 11:1153–1158. https://doi.org/10.1097/00001756-200004270-00003

  16. Möller A, Wiedemann G, Rohde U, Backmund H, Sonntag A (1994) Correlates of cognitive impairment and depressive mood disorder in multiple sclerosis. Acta Psychiatr Scand 89:117–121. https://doi.org/10.1111/j.1600-0447.1994.tb01497.x

    Article  PubMed  Google Scholar 

  17. Kallaur AP, Lopes J, Oliveira SR, Simão ANC, Reiche EMV, de Almeida ERD, Morimoto HK, de Pereira WLCJ, Alfieri DF, Borelli SD, Kaimen-Maciel DR, Maes M (2016) Immune-inflammatory and oxidative and nitrosative stress biomarkers of depression symptoms in subjects with multiple sclerosis : increased peripheral inflammation but less acute neuroinflammation. Mol Neurobiol 53:5191–5202. https://doi.org/10.1007/s12035-015-9443-4

    Article  CAS  PubMed  Google Scholar 

  18. Rossi S, Studer V, Motta C, Polidoro S, Perugini J, Macchiarulo G, Giovannetti AM, Pareja-Gutierrez L, Calò A, Colonna I, Furlan R, Martino G, Centonze D (2017) Neuroinflammation drives anxiety and depression in relapsing-remitting multiple sclerosis. Neurology 89:1338–1347. https://doi.org/10.1212/WNL.0000000000004411

    Article  CAS  PubMed  Google Scholar 

  19. Calabrese M, Magliozzi R, Ciccarelli O, Geurts JJG, Reynolds R, Martin R (2015) Exploring the origins of grey matter damage in multiple sclerosis. Nat Rev Neurosci 16:147–158. https://doi.org/10.1038/nrn3900

    Article  CAS  PubMed  Google Scholar 

  20. Zorzon M, de Masi R, Nasuelli D, Ukmar M, Pozzi Mucelli R, Cazzato G, Bratina A, Zivadinov R (2001) Depression and anxiety in multiple sclerosis. A clinical and MRI study in 95 subjects. J Neurol 248:416–421. https://doi.org/10.1007/s004150170184

    Article  CAS  PubMed  Google Scholar 

  21. Zorzon M, Zivadinov R, Nasuelli D et al (2002) Depressive symptoms and MRI changes in multiple sclerosis. Eur J Neurol 9:491–496. https://doi.org/10.1046/j.1468-1331.2002.00442.x

  22. Feinstein A, Roy P, Lobaugh N et al (2004) Structural brain abnormalities in multiple sclerosis patients with major depression. Neurology 62:586–590. https://doi.org/10.1212/01.wnl.0000110316.12086.0c

  23. Stuke H, Hanken K, Hirsch J et al (2016) Cross-sectional and longitudinal relationships between depressive symptoms and brain atrophy in MS patients. 10:1–8. https://doi.org/10.3389/fnhum.2016.00622

  24. Pravatà E, Rocca MA, Valsasina P et al (2017) Gray matter trophism, cognitive impairment, and depression in patients with multipls sclerosis. Mult Scler J 23:1864–1874. https://doi.org/10.1177/2040620717690316

    Article  Google Scholar 

  25. Nygaard GO, Walhovd KB, Sowa P, Chepkoech JL, Bjørnerud A, Due-Tønnessen P, Landrø NI, Damangir S, Spulber G, Storsve AB, Beyer MK, Fjell AM, Celius EG, Harbo HF (2015) Cortical thickness and surface area relate to specific symptoms in early relapsing–remitting multiple sclerosis. Mult Scler J 21:402–414. https://doi.org/10.1177/1352458514543811

    Article  Google Scholar 

  26. Koolschijn PCMP, Van Haren NEM, Lensvelt-Mulders GJLM et al (2009) Brain volume abnormalities in major depressive disorder: a meta-analysis of magnetic resonance imaging studies. Hum Brain Mapp 30:3719–3735. https://doi.org/10.1002/hbm.20801

    Article  PubMed  PubMed Central  Google Scholar 

  27. Gold SM, Kern KC, O’Connor MF et al (2010) Smaller cornu ammonis 23/dentate gyrus volumes and elevated cortisol in multiple sclerosis patients with depressive symptoms. Biol Psychiatry 68:553–559. https://doi.org/10.1016/j.biopsych.2010.04.025

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Kiy G, Lehmann P, Hahn HK, Eling P, Kastrup A, Hildebrandt H (2011) Decreased hippocampal volume, indirectly measured, is associated with depressive symptoms and consolidation deficits in multiple sclerosis. Mult Scler J 17:1088–1097. https://doi.org/10.1177/1352458511403530

    Article  Google Scholar 

  29. Gobbi C, Rocca MA, Pagani E, Riccitelli GC, Pravatà E, Radaelli M, Martinelli-Boneschi F, Falini A, Copetti M, Comi G, Filippi M (2014) Forceps minor damage and co-occurrence of depression and fatigue in multiple sclerosis. Mult Scler J 20:1633–1640. https://doi.org/10.1177/1352458514530022

    Article  CAS  Google Scholar 

  30. Gold SM, Connor MO, Gill R et al (2014) Detection of altered hippocampal morphology in multiple sclerosis-associated depression using automated surface mesh modeling. 37:30–37. https://doi.org/10.1002/hbm.22154

  31. Feinstein A, O’Connor P, Akbar N et al (2010) Diffusion tensor imaging abnormalities in depressed multiple sclerosis patients. Mult Scler 16:189–196. https://doi.org/10.1177/1352458509355461

    Article  CAS  PubMed  Google Scholar 

  32. Shen Y, Bai L, Gao Y, Cui F, Tan Z, Tao Y, Sun C, Zhou L (2014) Depressive symptoms in multiple sclerosis from an in vivo study with TBSS. 2014: https://doi.org/10.1155/2014/148465

  33. Nigro S, Passamonti L, Riccelli R, Toschi N, Rocca F, Valentino P, Nisticò R, Fera F, Quattrone A (2015) Structural ‘connectomic’ alterations in the limbic system of multiple sclerosis patients with major depression. Mult Scler J 21:1003–1012. https://doi.org/10.1177/1352458514558474

    Article  Google Scholar 

  34. Rojas JI, Sanchez F, Patrucco L, Miguez J, Besada C, Cristiano E (2017) Brain structural changes in patients in the early stages of multiple sclerosis with depression. Neurol Res 39:596–600. https://doi.org/10.1080/01616412.2017.1298279

    Article  CAS  PubMed  Google Scholar 

  35. Rocca MA, Pravatà E, Valsasina P, Radaelli M, Colombo B, Vacchi L, Gobbi C, Comi G, Falini A, Filippi M (2015) Hippocampal-DMN disconnectivity in MS is related to WM lesions and depression. Hum Brain Mapp 36:5051–5063. https://doi.org/10.1002/hbm.22992

    Article  PubMed  PubMed Central  Google Scholar 

  36. Bonavita S, Sacco R, Esposito S et al (2017) Default mode network changes in multiple sclerosis : a link between depression and cognitive impairment?:27–36. https://doi.org/10.1111/ene.13112

  37. van Geest Q, Boeschoten RE, Keijzer MJ, Steenwijk MD, Pouwels PJW, Twisk JWR, Smit JH, Uitdehaag BMJ, Geurts JJG, van Oppen P, Hulst HE (2019) Fronto-limbic disconnection in patients with multiple sclerosis and depression. Mult Scler J 25:715–726. https://doi.org/10.1177/https

    Article  Google Scholar 

  38. Riccelli R, Passamonti L, Cerasa A, Nigro S, Cavalli SM, Chiriaco C, Valentino P, Nisticò R, Quattrone A (2016) Individual differences in depression are associated with abnormal function of the limbic system in multiple sclerosis patients. Mult Scler J 22:1094–1105. https://doi.org/10.1177/1352458515606987

    Article  Google Scholar 

  39. Fassbender K, Schmidt R, Mo R, Ku J (2017) Mood disorders and dysfunction of the hypothalamic-pituitary-adrenal axis in multiple sclerosis. Arch Neurol 55:66–72

    Article  Google Scholar 

  40. Kantorová E, Poláček H, Bittšanský M, Baranovičová E, Hnilicová P, Čierny D, Sivák Š, Nosáľ V, Zeleňák K, Kurča E (2017) Hypothalamic damage in multiple sclerosis correlates with disease activity, disability , depression , and fatigue. Neurol Res 6412:1–8. https://doi.org/10.1080/01616412.2016.1275460

    Article  CAS  Google Scholar 

  41. Yaldizli PIK, Yonekawa T et al (2016) The association between olfactory bulb volume, cognitive dysfunction, physical disability and depression in multiple sclerosis. Eur J Neurol 23:510–519. https://doi.org/10.1111/ene.12891

    Article  CAS  PubMed  Google Scholar 

  42. Zivadinov R, Zorzon M, Bragadin LM et al (1999) Olfactory loss in multiple sclerosis. J Neurol Sci 168:127–130

    Article  CAS  Google Scholar 

  43. Gobbi C, Rocca M, Riccitelli G, Pagani E, Messina R, Preziosa P, Colombo B, Rodegher M, Falini A, Comi G, Filippi M (2014) Influence of the topography of brain damage on depression and fatigue in patients with multiple sclerosis. Mult Scler J 20:192–201. https://doi.org/10.1177/1352458513493684

    Article  CAS  Google Scholar 

  44. Leonard BE (2018) Inflammation and depression: a causal or coincidental link to the pathophysiology ? Acta Neuropsychiatr 30:1–16. https://doi.org/10.1017/neu.2016.69

    Article  PubMed  Google Scholar 

  45. Grech LB, Butler E, Stuckey S, Hester R (2019) Neuroprotective benefits of antidepressants in multiple sclerosis: are we missing the mark? J Neuropsychiatry Clin Neurosci. https://doi.org/10.1176/appi.neuropsych.18070164

Download references

Author information

Authors and Affiliations

  1. Department of Rehabilitation, C.R.R.F. “Mons. L. Novarese”, Loc. Trompone, Moncrivello, VC, Italy

    Fabio Giuseppe Masuccio, Giulia Gamberini & Claudio Solaro

  2. Multiple Sclerosis Center, Neurology section, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy

    Massimiliano Calabrese

Authors
  1. Fabio Giuseppe Masuccio
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Giulia Gamberini
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Massimiliano Calabrese
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Claudio Solaro
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Claudio Solaro.

Ethics declarations

Conflict of interest

Fabio Giuseppe Masuccio and Giulia Gamberini have nothing to disclose. Massimiliano Calabrese received honoraria for research or speaking from Sanofi-Genzyme, Merck-Serono, Biogen Idec, Teva, Novartis Pharma and Roche and funds for travel from Sanofi-Genzyme, Merck-Serono, Biogen Idec, Teva, Novartis Pharma and Roche. Claudio Solaro served on the advisory boards of Biogen Idec and Merck Serono. He received speaking honoraria from Bayer Schering, Biogen Idec, Merck Serono, Almirall, Teva and Genzyme. He received research grants and support from the Italian MS Society Research Foundation (Fondazione Italiana Sclerosi Multipla).

Ethical approval

None.

Informed consent

None.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Key points

• Patients with multiple sclerosis experience depression/depressive symptoms more frequently than the general population. Depression in patients with multiple sclerosis has to be considered as a process with a multifactorial aetiology (genetic, psychosocial, immune-inflammatory factors, brain damage).

• Structural and functional brain damage has been consistently associated with depression and/or depressive symptoms in patients with multiple sclerosis.

• Lack of a former depression diagnosis according to DSM criteria is present in several papers. Only few longitudinal studies are available.

• The available studies show high variability in design, inclusion criteria and sample size, leading to difficulty in drawing conclusion.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Masuccio, F.G., Gamberini, G., Calabrese, M. et al. Imaging and depression in multiple sclerosis: a historical perspective. Neurol Sci 42, 835–845 (2021). https://doi.org/10.1007/s10072-020-04951-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-020-04951-z

Keywords

Search

Navigation